Yuchen Han
Lawyers
Associate in our Corporate practice, currently assigned as a Legal Manager in Beijing.
Experience highlights
- WuXi XDC Cayman HK$3.68 billion IPO
- CARsgen Therapeutics $400 million Hong Kong IPO and global offering
- JOINN Laboratories $844 million Hong Kong IPO and global offering
- Antengene $357 million Hong Kong IPO and global offering
- ADC Therapeutics $267 million U.S. IPO
- Black Diamond Therapeutics $231.3 million U.S. IPO
- China South City Holdings $250 million high-yield notes offering and concurrent cash tender offer
- Magenta Therapeutics $69 million follow-on offering of common stock
- Amerant Bancorp $60 million notes offering
- LivaNova USA $287.5 million cash exchangeable senior notes offering
- Ralph Lauren Corporation $1.25 billion notes offering
- Lennox $600 Million senior notes offering
- IDEX Corporation $500 million notes offering
- Huntington Ingalls Industries $1 billion senior offering
- GFL Environmental US IPO of $1.425 billion of subordinate voting shares and $775 million of tangible equity units
Education
J.D., Harvard Law School
- cum laude
Ph.D., Molecular Biology, Princeton University
M.A., Molecular Biology, Princeton University
B.Sc., Biology, Tsinghua University
Professional history
- Davis Polk since 2019
Qualifications and admissions
- State of New York